Cargando…
Does subcutaneous administration of recombinant human erythropoietin increase thrombotic events in total hip arthroplasty? A prospective thrombelastography analysis
BACKGROUND: Anemia is one of severe complications in the perioperative period of total hip arthroplasty (THA). Erythropoietin (EPO) has been considered to improve patients’ anemia state, but its efficiency and safety remains controversial. METHODS: A total of 152 patients who underwent total hip art...
Autores principales: | Ruan, Ru-xin, Bai, Chao-wen, Zhang, Le, Huang, Chao-ran, Pan, Sheng, Zhang, Xing-chen, Zhu, Zheng-ya, Zheng, Xin, Guo, Kai-jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678274/ https://www.ncbi.nlm.nih.gov/pubmed/33213494 http://dx.doi.org/10.1186/s13018-020-02083-w |
Ejemplares similares
-
Comparison of Oral Recombinant Erythropoietin and Subcutaneous Recombinant Erythropoietin in Prevention of Anemia of Prematurity
por: Saeidi, R, et al.
Publicado: (2012) -
Thrombelastography and sepsis
por: Puana, Rudolph, et al.
Publicado: (2007) -
Application of thrombelastography (TEG) for safety evaluation of tranexamic acid in primary total joint arthroplasty
por: Wu, Xiang-Dong, et al.
Publicado: (2019) -
Identification of hypercoagulability with thrombelastography in patients with hip fracture receiving thromboprophylaxis
por: You, Daniel, et al.
Publicado: (2021) -
Changes of thrombelastography in patients undergoing elective primary total knee and total hip replacement with low molecular heparin prophylaxis
por: Yang, Yi, et al.
Publicado: (2014)